Advances in the treatment of BRAF-mutant low-grade glioma with MAPK inhibitors

Transl Pediatr. 2024 Mar 27;13(3):513-517. doi: 10.21037/tp-23-541. Epub 2024 Mar 18.

Author

Peter J Houghton¹

Affiliation

¹ Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

No abstract available

Keywords: BRAF mutation; Pediatric; low-grade glioma; molecular targeted therapies; pediatric clinical trials.

Publication types

Editorial
Comment